Nuvation Bio Inc. - Common Stock (NUVB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
NUVB on NYSE
Shares outstanding
339,200,672
Price per share
$8.96
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
220,565,926
Total reported value
$817,904,643
% of total 13F portfolios
0%
Share change
-4,194,218
Value change
-$1,513,463
Number of holders
202
Price from insider filings
$8.96
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Nuvation Bio Inc. - Common Stock (NUVB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +11% $110,306,310 +$11,583,764 50,599,225 +12% FMR LLC 31 Mar 2025
BlackRock, Inc. 6.4% +30% $42,332,244 +$10,273,842 21,708,843 +32% BlackRock, Inc. 30 Jun 2025

As of 30 Sep 2025, 202 institutional investors reported holding 220,565,926 shares of Nuvation Bio Inc. - Common Stock (NUVB). This represents 65% of the company’s total 339,200,672 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Nuvation Bio Inc. - Common Stock (NUVB) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 15% 50,570,474 -0.92% 0.01% $187,110,754
Decheng Capital LLC 7.7% 25,954,439 0% 17% $96,031,424
BlackRock, Inc. 7.3% 24,604,159 -4.4% 0% $91,035,389
VANGUARD GROUP INC 4.6% 15,454,595 -2.8% 0% $57,182,001
Laurion Capital Management LP 2.9% 9,705,532 -5.2% 4.9% $35,910,468
Omega Fund Management, LLC 2.6% 8,831,089 -20% 15% $32,675,029
STATE STREET CORP 1.8% 6,089,185 +9.5% 0% $22,529,985
GEODE CAPITAL MANAGEMENT, LLC 1.7% 5,887,755 -1.8% 0% $21,788,082
MILLENNIUM MANAGEMENT LLC 1.4% 4,852,218 -9.8% 0.01% $17,953,207
Nuveen, LLC 1.3% 4,566,701 +207% 0% $16,896,794
TANG CAPITAL MANAGEMENT LLC 1.2% 4,200,000 +7.7% 0.6% $15,540,000
ABRAMS CAPITAL MANAGEMENT, L.P. 1.1% 3,811,513 0% 0.23% $14,102,598
DIMENSIONAL FUND ADVISORS LP 0.98% 3,321,249 +20% 0% $12,275,869
Redmile Group, LLC 0.89% 3,031,009 0% 1.1% $11,214,733
Aisling Capital Management LP 0.87% 2,960,659 +17% 2.4% $10,954,438
Octagon Capital Advisors LP 0.78% 2,633,334 -66% 1.5% $9,743,336
TWO SIGMA INVESTMENTS, LP 0.7% 2,377,570 +96% 0.01% $8,797,009
JANE STREET GROUP, LLC 0.68% 2,322,233 0.01% $8,592,262
CITADEL ADVISORS LLC 0.68% 2,304,453 -58% 0.01% $8,526,476
ARMISTICE CAPITAL, LLC 0.68% 2,296,000 +359% 0.27% $8,495,200
NORTHERN TRUST CORP 0.62% 2,117,672 +1.6% 0% $7,835,386
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.61% 2,055,495 -3.5% 0% $7,605,332
AQR CAPITAL MANAGEMENT LLC 0.6% 2,034,211 +79% 0% $7,526,581
Pale Fire Capital SE 0.43% 1,444,647 +1410% 0.59% $5,345,194
MORGAN STANLEY 0.39% 1,319,495 +9.1% 0% $4,882,133

Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,826,007 $25,291,659 +$16,443,611 $8.96 18
2025 Q3 220,565,926 $817,904,643 -$1,513,463 $3.70 202
2025 Q2 224,729,650 $439,155,420 +$34,613,471 $1.95 179
2025 Q1 207,335,118 $364,911,263 +$18,852,443 $1.76 159
2024 Q4 197,748,566 $526,027,669 +$38,581,638 $2.66 159
2024 Q3 187,137,100 $428,593,958 +$73,128,321 $2.29 153
2024 Q2 153,048,262 $446,948,909 +$52,594,408 $2.92 146
2024 Q1 134,652,746 $490,113,918 +$5,142,866 $3.64 122
2023 Q4 134,270,272 $202,718,680 -$2,287,216 $1.51 116
2023 Q3 136,892,011 $183,439,434 -$9,239,486 $1.34 122
2023 Q2 139,011,387 $250,194,724 +$3,219,600 $1.80 120
2023 Q1 137,479,282 $228,214,660 -$4,709,474 $1.66 126
2022 Q4 139,580,600 $267,992,788 -$12,224,298 $1.92 123
2022 Q3 141,780,239 $317,588,133 -$44,323,294 $2.24 116
2022 Q2 155,298,098 $503,167,223 -$21,514,875 $3.24 116
2022 Q1 159,104,350 $836,898,347 +$14,198,236 $5.26 112
2021 Q4 155,258,449 $1,319,350,594 +$21,011,876 $8.50 103
2021 Q3 151,280,175 $1,503,381,648 +$33,688,697 $9.94 97
2021 Q2 147,981,823 $1,364,632,796 +$15,849,184 $9.31 97
2021 Q1 145,559,447 $1,478,100,000 +$1,473,836,329 $10.45 72